Curaleaf (OTCMKTS:CURLF) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Curaleaf (OTCMKTS:CURLF) announced its quarterly earnings results on Wednesday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01), reports. Curaleaf had a negative return on equity of 14.75% and a negative net margin of 18.59%. The company had revenue of $330.53 million for the quarter, compared to analyst estimates of $345.83 million.

Curaleaf Trading Down 5.5 %

OTCMKTS CURLF opened at $2.13 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.50 and a current ratio of 1.09. The firm has a market cap of $1.38 billion, a PE ratio of -6.09 and a beta of 0.86. Curaleaf has a one year low of $2.07 and a one year high of $6.40. The firm’s fifty day moving average is $2.97 and its two-hundred day moving average is $3.80.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CURLF. Needham & Company LLC reiterated a “buy” rating and set a $6.25 price target on shares of Curaleaf in a research note on Thursday, August 8th. Cormark lowered shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.